About: Adolescent Substance Use and Rx Drug Misuse CME/CEs

Getting Started

View / download supplemental resources [DOCX - 2 MB]

These courses offer multiple types of continuing education credit.

• Physicians—earn up to 1.00 AMA PRA Category 1 Credit(s) ^TM
  • 1.00 AAFP Prescribed Credits available
  • 1.00 AAP Credits available
• Doctors of Osteopathic Medicine—earn up to 1.0 AOA Category 2B CME Credit
  • Visit the AOA Website to take the courses for AOA credit
• Nurses—earn up to 1.00 ANCC Contact Hour
• Dentists—earn up to 1 ADA credit

​Start the Course
(ACCME, ANCC, ADA credit)

Please see below for full accreditation information and instructions for claiming credit.

Full Accreditation Information

Target Audience

This activity has been designed to meet the educational needs of clinicians including, physicians, physician assistants, nurse practitioners, nurses, and dentists/oral maxillofacial surgeons, involved in the care of adolescent patients.

Educational Objectives

After completing this activity, the participant should be better able to:

Part 1

1. Describe the prevalence of substance use and prescription drug misuse among adolescents
2. Explain why adolescents are at high risk of developing a substance use disorder and how clinicians can help prevent it
3. Demonstrate strategies to build trust with adolescent patients and ensure confidentiality when addressing substance use and prescription drug misuse
4. Summarize ways to identify substance use and prescription drug misuse in adolescent patients, including determining their level of risk

Part 2

5. Discuss strategies to address substance use and prescription drug misuse in adolescent patients based on their level of use
6. Summarize when and how to follow up with adolescent patients who use substances or misuse prescription drugs

Education Coalition

This activity was developed by an education Coalition of experts and medical professional organization representatives. The Coalition comprises the following organizations and experts:

Type of Reviewer: Organization/ Expert Consultant	Reviewer Name
California Academy of Family Physicians (CAFP)	Cynthia Kear, Senior Vice President
American Society of Addiction Medicine (ASAM)	Jennifer Butchart, Education Coordinator   Penny Mills, Executive Vice President / CEO      Arlene Deverman, VP Professional Development
American Osteopathic Association (AOA)	Stephanie Townsell, Director, Public Health Marla Kushner, DO
American Association of Nurse Practitioners (AANP)	Anne Norman, DNP, APRN, FNP-C, FAANP, Vice President of Education and Accreditation
American Academy of Pediatrics (AAP)	Renee Jarrett, Manager, Mental Health and Foster Care Initiatives Div of Developmental Pediatrics and Preventive Services
American Academy of Physician Assistants (AAPA)	Daniel Pace, Vice President, Education Marie-Michele Leger, MPH, PA-C, Director, Clinical Education Sara Evans, PMP, Project Manager, Quality Improvement Initiatives
American Association of Oral and Maxillofacial Surgeons (AAOMS)	Vincent DiFabio, DDS
Consultant	Samantha Mattiucci, PharmD, Director of Medical Education
Consultant	Jan Schultz, BSN, MSN, RN, CCMEP, Director of Education Outcomes and Accreditation Services
Consultant	Dan Alford, MD, Associate Professor of Medicine, Assistant Dean and Program Director of the Addiction Medicine Residency program at Boston University School of Medicine
Consultant	Sharon Levy, Director, Adolescent Substance Abuse Program (ASAP)Assistant Professor in Pediatrics,  Boston Children's Hospital
Consultant	Jeff Baxter, MD, Assistant Professor Department of Family Medicine and Community Health, University of Massachusetts Medical School
Consultant	Marc Fishman, MD
Consultant	Carol Havens, MD

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The Education Coalition members reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Marc Fishman, MD discloses the following: Consulting Fees: US World Meds; Contracted Research: Media Rez, US World Meds

Ownership Interest: Maryland Treatment Centers

The following Education Coalition members have nothing to disclose: Cynthia Kear, Jennifer Butchart, Penny Mills, Arlene Deverman, Stephanie Townsell, Marla Kushner, Anne Norman, Renee Jarrett, Daniel Pace, Marie-Michele Leger, Sara Evans, Vincent DiFabio, Jan Schultz, Dan Alford, Sharon Levy, Jeff Baxter, Marc Fishman, and Carol Havens

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following National Institute on Drug Abuse planners and managers, Elisabeth Davis; Carol Krause; Josie Anderson; Jack Stein, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months

The following JBS International, Inc. planners and managers, Candace Baker; Susan Hayashi; Laura Nolan; Bethel Arya; and Veronica Junghahn, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and National Institute for Drug Abuse.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

American Dental Association CERP Recognition

This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint sponsorship efforts between Postgraduate Institute for Medicine and the National Institute for Drug Abuse.

Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.  ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry.

Postgraduate Institute for Medicine designates this activity for 1.0 continuing education credit.

Additional Physician Continuing Medical Education

This activity has been reviewed and is acceptable for up to 1.00 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 06/30/2017. Term of approval is for two years from this date.

This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Instructions for Claiming Credit

For Physicians, Registered Nurses and Dentists please follow the instructions below:

PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please follow the steps below:

1. Go to CME University at: www.cmeuniversity.com and register or login
2. Once logged in, click on “Find Post-test/Evaluation by Course” at the top of the page
3. Type in 11118 (for Part 1) or 12614 (for Part 2) in the box; hit enter
4. Click on the activity title
5. Complete the online posttest and evaluation and obtain your CME certificate to download and/or print for your files.

Upon completion of the online posttest and evaluation form, you will have immediate access to a certificate of attendance to print or save for your files. You can save your certificate by selecting the “Save” option on the print screen. 

For any questions relating to the physician, nursing or dentist accreditation, please contact PIM via:  inquiries@pimed.com

For Nurse Practitioners follow the instructions below:

• Visit the AANP’s Website (Part 1 and Part 2) to take the course for AANP credit.

For Physician Assistants follow the instructions below:

• Visit the AAPA’s Website to take the course for AAPA credit.

Doctors of Osteopathic Medicine—earn up to 1.0 AOA Category 2B CME Credit

• Visit the AOA Website to take the courses for AOA credit

Media

Internet activity

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.